Dial Schedule M: India’s drug manufacturing practices to undergo major overhaul by Lexplosion | Feb 28, 2024 | Compliance, Legal analysis, PharmaceuticalsIf you are a pharmaceutical company in India with a turnover of more than Rs. 250 crores, you only... Read More
